Alpha-Mannosidosis is a rare disease, and its timely diagnosis has the potential to influence patient outcomes since management and preventive therapies can be initiated at an early stage. Currently, early diagnosis is mainly hampered by:1
- the rarity of the disease;
- the variety of signs/symptoms observed;
- the wide range of disease severity.
A standardised diagnostic algorithm might help to overcome this gap.1
In 2019, with no internationally recognized guidelines for early diagnosis of Alpha-Mannosidosis, an international working group of experts met to establish an algorithm to help general practitioners and specialists (metabolic and non-metabolic) achieve early diagnosis and initiate adequate treatment as soon as possible.1
Two consensus proposals were developed for diagnostic algorithms of Alpha-Mannosidosis:




